Galenica (XSWX:GALE) Cash Flow from Operations: CHF300 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALE Galenica Ltd XSWX:GALE
83 GF Score
Price CHF85.95
GF Value CHF86.65
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Galenica Cash Flow from Operations?

Galenica XSWX:GALE -1.83% 83 Cash Flow from Operations is CHF300 Mil as of Dec. 2025. GuruFocus rates XSWX:GALE with a GF Score™ of 83/100 and a GF Value™ of CHF86.65 (Fairly Valued). The stock has 1 warning sign investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2025, Galenica's Net Income From Continuing Operations was CHF95 Mil. Its Depreciation, Depletion and Amortization was CHF61 Mil. Its Change In Working Capital was CHF35 Mil. Its cash flow from deferred tax was CHF21 Mil. Its Cash from Discontinued Operating Activities was CHF0 Mil. Its Asset Impairment Charge was CHF0 Mil. Its Stock Based Compensation was CHF5 Mil. And its Cash Flow from Others was CHF-26 Mil. In all, Galenica's Cash Flow from Operations for the six months ended in Dec. 2025 was CHF191 Mil.


Galenica  (XSWX:GALE) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Galenica's net income from continuing operations for the six months ended in Dec. 2025 was CHF95 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Galenica's depreciation, depletion and amortization for the six months ended in Dec. 2025 was CHF61 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Galenica's change in working capital for the six months ended in Dec. 2025 was CHF35 Mil. It means Galenica's working capital increased by CHF35 Mil from Jun. 2025 to Dec. 2025 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Galenica's cash flow from deferred tax for the six months ended in Dec. 2025 was CHF21 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Galenica's cash from discontinued operating Activities for the six months ended in Dec. 2025 was CHF0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Galenica's asset impairment charge for the six months ended in Dec. 2025 was CHF0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Galenica's stock based compensation for the six months ended in Dec. 2025 was CHF5 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Galenica's cash flow from others for the six months ended in Dec. 2025 was CHF-26 Mil.


Galenica Cash Flow from Operations Related Terms


Galenica Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Galenica's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galenica Cash Flow from Operations Chart

Galenica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 333.10 236.87 225.71 264.70 299.77

Galenica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 220.74 43.83 220.88 108.93 190.83
XSWX:GALE
83GF Score
Galenica Ltd XSWX:GALE
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galenica Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Galenica's Cash Flow from Operations for the fiscal year that ended in Dec. 2025 is calculated as:

Galenica's Cash Flow from Operations for the quarter that ended in Dec. 2025 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF300 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of CHF300 Mil mean?
Galenica (XSWX:GALE) has a Cash Flow from Operations of CHF300 Mil as of Dec. 2025. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Galenica and its competitors.
Is Galenica's Cash Flow from Operations too high?
Galenica's current Cash Flow from Operations is CHF300 Mil. Overall, Galenica has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Galenica's Cash Flow from Operations compare to MCK and COR?
Galenica's Cash Flow from Operations of CHF300 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Medical Distribution company?
A good Cash Flow from Operations depends on the Medical Distribution industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Galenica and its competitors. Galenica's current Cash Flow from Operations is CHF300 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Based on GuruFocus' analysis, Galenica (XSWX:GALE) is currently considered Fairly Valued. The stock's GF Value™ is CHF86.65, compared to a current price of CHF85.95 — trading 0.8% below its estimated fair value. The current Cash Flow from Operations is CHF300 Mil. Galenica's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Galenica (XSWX:GALE), the current Cash Flow from Operations is CHF300 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (XSWX:GALE) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be undervalued. The current stock price of CHF85.95 is trading 0.8% below its estimated GF Value™ of CHF86.65. GuruFocus considers Galenica to be Fairly Valued.

Key valuation signals for XSWX:GALE:

  • Cash Flow from Operations: CHF300 Mil
  • GF Value™: CHF86.65 vs. price of CHF85.95 (0.8% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the XSWX:GALE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
83GF Score

Get the complete analysis for XSWX:GALE

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF85.95
Price
CHF86.65
GF Value